medline.ch Urologie-Nephrologie

	Identification of a personalized eGFR threshold improves the prediction of kidney failure risk after transplantation. Commun Med (Lond) Savvopoulos SV, Scheffner I, Reppas A, Gwinner W, Hatzikirou H. PMID: 41917186 [PubMed - as supplied by publisher]
	Continuous renal replacement therapy attenuates endothelial injury biomarkers in pediatric sepsis: a prospective cohort study. Ren Fail Miao H, Wang C, Cui Y, Xiong X, Ren Y, Lv Z, Zhang Y. PMID: 41916904 [PubMed - indexed for MEDLINE]
	Re: European Study of Prostate Cancer Screening - 23-Year Follow-up. Eur Urol Montironi R, Giannarini G, Cimadamore A, Lopez-Beltran A, Rogers ET, Cheng L. PMID: 41916801 [PubMed - as supplied by publisher]
	New strategies to empower patients with chronic kidney disease in phosphorus control (empower-PHOS). Nefrologia (Engl Ed) Arenas Jiménez MD, García de Polavieja MD, Escribano S, Audije-Gil J, Sánchez-Tocino ML, Henríquez-Palop F, Antón Pérez G, Yetman D, Pereira M, Molina P, Auxiliadora Bajo M, Jesús Lloret M, Quilis A, Fernández C, García Monteavaro C, María León L, Botella A, Ballart J, Durbá A, Furaz K, González Parra E, Handel M, Delgado Yagüe M, Antonio Herrero J, Dapena Bielva F, Grupo de trabajo Empower-PHOS. PMID: 41916792 [PubMed - as supplied by publisher]
	Strategies for prevention, early detection and management of penile and testicular cancer in primary healthcare: scoping review protocol. BMJ Open Sant'Ana RSE, de Matos WDV, Amaral JBDA, Calleja S, Maheu C, Hart NH, Rabelo AL, Sousa AR. PMID: 41916624 [PubMed - indexed for MEDLINE]
	BPI26-007: Avoiding Unnecessary Biopsies for Non-Clinically Significant Prostate Cancer in Patients With PSA 4-20 ng/mL Using PRIMARY Score â‰¤3 and PSAD â‰¤0.2 ng/mL/cmÂ³: A Real-World, Dual-Centre Study From China. J Natl Compr Canc Netw He J, Qi L, Chen M, Hu S, Gao X, Tang Y, Chen S, Cai Y. PMID: 41916360 [PubMed - in process]
	NMR-based serum metabolomics reveals diabetes-linked metabolic reprogramming in early-stage chronic kidney disease. J Pharm Biomed Anal Gupta U, Sahu A, Kaul A, Mishra J, Yadav SC, Behera M, Baishya B, Sinha N. PMID: 41916254 [PubMed - as supplied by publisher]
	Prostate MRI quality assessment using PI-QUAL version 2: Comparative analysis between 1.5Â T and 3Â T scanners and its association with T-staging agreement. Eur J Radiol Song JS, Jang W. PMID: 41916137 [PubMed - as supplied by publisher]
	Urinary CXCL9 for kidney allograft rejection: A systematic review and meta-analysis of diagnostic performance across clinical scenarios. Transplant Rev (Orlando) Lou Y, Ma C, Zhang X, Zhang M, Chai H, Wang C, Liu X. PMID: 41916065 [PubMed - as supplied by publisher]
	Optimizing the Systemic Treatment for Metastatic Castration-Resistant Prostate Cancer in Lower-Middle-Income Countries: A 7-Year Analysis of the Brazilian Public Health System. JCO Glob Oncol Monteiro FSM, Souza VC, da Trindade KM, E Silva AG, Mota A, Bastos DA, Valverde DA, Abboud HS, Herchenhorn D, Soares A. PMID: 41915874 [PubMed - indexed for MEDLINE]
	Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study. Cardiorenal Med Hidaka S, Yamano M, Mochida Y, Tanabe K, Kobayashi S. PMID: 41915605 [PubMed - as supplied by publisher]
	Effect of finerenone treatment discontinuation on kidney and cardiovascular outcomes: a FIDELITY analysis. Am J Nephrol Singh AK, Anker SD, Pitt B, Rossing P, Ruilope LM, Ahlers C, Farag YMK, Lambelet M, Brinker M, Rohwedder K, Zheng Z, Filippatos G. PMID: 41915602 [PubMed - as supplied by publisher]
	Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancer. J Clin Invest Mendes L, Dutey-Magni PF, Grist E, Sachdeva A, Santos Vidal S, Lall S, Parry MA, Amos CL, Atako NB, Wingate A, Wetterskog D, Sydes MR, Parker CC, Clarke N, Sweeney CJ, Parmar MK, Brown LC, James ND, Berney DM, Attard G. PMID: 41915426 [PubMed - as supplied by publisher]
	Cardiovascular and Renal Outcomes Among Kidney Transplant Recipients With Metabolic Syndrome: A Systematic Review and Meta-Analysis. Clin Transplant Lim MY, Shee LY, Wong ZY, Wong WK, Ng KT, Moy FM, Lim SK. PMID: 41915369 [PubMed - indexed for MEDLINE]
	Emerging roles for the epigenetic modifiers PBRM1 SETD2 and BAP1 in clear cell renal cell carcinoma pathogenesis and prognosis beyond VHL. Discov Oncol Jixiang B, Xin C, Xiaoxuan P, Mingli S, Jieru H, Shuhui W. PMID: 41915349 [PubMed - as supplied by publisher]
	Testosterone-Sparing Treatment Strategies for Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Curr Oncol Rep Najdawi F, Sayyid RK, Ahlering T, Lee DI, Dobbs RW, Shahait M. PMID: 41915319 [PubMed - indexed for MEDLINE]
	Obesity and Waitlist Access to Out-of-Sequence Deceased Donor Kidney Transplantation. Clin Transplant Montgomery JR, Patel SS, Akizhanov D, Estrada MM, Liyanage LN, Lonze BE, Segev DL, Gentry SE, Massie AB, Orandi BJ. PMID: 41915312 [PubMed - indexed for MEDLINE]
	The role of apoptotic genetic polymorphisms in prostate cancer susceptibility in a North West Spain population. Mol Genet Genomics López-Trigo N, Caeiro B, Pérez-Pérez J, Rodríguez-Alonso A, Aguín N, Rodríguez JA, Luis JR. PMID: 41915239 [PubMed - indexed for MEDLINE]
	The Prognostic Value of TyG Index and Right Ventricular Function in HFpEF Patients With Chronic Kidney Disease. Echocardiography Liu J, Wang R, Shi W, Deng Y, Wang B, Li Y, Qin Y, Zhao F, Lu W, Chu A, Xie P. PMID: 41915081 [PubMed - indexed for MEDLINE]
	Improving membranous urethral length measurements on prostate MRI: a comparison of online training methods. Eur Radiol Goedegebuure EP, Boellaard TN, van Dijk-de Haan MC, Heijmink SWTPJ, Hagens MJ, Tissier R, van Griethuysen JJM, Khmelinkskii A, Beets-Tan RGH, Schoots IG, Lambregts DMJ, Membranous Urethral Length . PMID: 41915072 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 469011

Seite 1 von 23451

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung